0001842952-22-000075.txt : 20220812
0001842952-22-000075.hdr.sgml : 20220812
20220812163115
ACCESSION NUMBER: 0001842952-22-000075
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220812
FILED AS OF DATE: 20220812
DATE AS OF CHANGE: 20220812
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sahmoud Tarek
CENTRAL INDEX KEY: 0001861811
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40654
FILM NUMBER: 221160618
MAIL ADDRESS:
STREET 1: 3675 MARKET STREET
STREET 2: SUITE 200
CITY: PHILADELPHIA
STATE: PA
ZIP: 19104
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Context Therapeutics Inc.
CENTRAL INDEX KEY: 0001842952
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 863738787
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2001 MARKET STREET
STREET 2: SUITE 3915 UNIT #15
CITY: PHILADELPHIA
STATE: PA
ZIP: 19103
BUSINESS PHONE: 267-225-7416
MAIL ADDRESS:
STREET 1: 2001 MARKET STREET
STREET 2: SUITE 3915 UNIT #15
CITY: PHILADELPHIA
STATE: PA
ZIP: 19103
FORMER COMPANY:
FORMER CONFORMED NAME: Context Therapeutics LLC
DATE OF NAME CHANGE: 20210128
4
1
wf-form4_166033625278582.xml
FORM 4
X0306
4
2022-08-12
0
0001842952
Context Therapeutics Inc.
CNTX
0001861811
Sahmoud Tarek
2001 MARKET STREET
SUITE 3915, UNIT #15
PHILADELPHIA
PA
19103
0
1
0
0
Chief Medical Officer
Stock Option (right to buy)
1.96
2022-08-12
4
A
0
25000
0
A
2032-08-11
Common Stock
25000.0
25000
D
The option vests and becomes exercisable over a two-year period. Fifty percent (50%) of the option vests and becomes exercisable on June 17, 2023, and the balance vests in equal monthly installments (rounded down to the nearest whole share) over the remaining one year of the two-year period, subject to continued service with the Issuer.
/s/ Alex Levit, Attorney-in-Fact
2022-08-12